## Abstract Allogeneic hematopoietic stem cell transplantation (SCT) is a potentially curative treatment for patients with myelodysplastic syndrome (MDS). Relapses after transplantation however, are not uncommon and are usually due to reβemergence of a recipient derived, neoplastic, stem cell clone
Donor cell leukemia after allogeneic peripheral blood stem cell transplantation: a case report and literature review
β Scribed by Makoto Murata; Yuichi Ishikawa; Haruhiko Ohashi; Seitaro Terakura; Kazutaka Ozeki; Hitoshi Kiyoi; Tomoki Naoe
- Book ID
- 107618546
- Publisher
- Carden Jennings Publishing
- Year
- 2008
- Tongue
- English
- Weight
- 169 KB
- Volume
- 88
- Category
- Article
- ISSN
- 0925-5710
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
We report the case of a man with chronic myelocytic leukemia (CML) and a 46,XY,t(5;9;22) karyotype who developed acute myelocytic leukemia (AML) with a 45,X,t(8;21) karyotype 11 years after bone marrow transplantation (BMT) from his HLA-matched sister. Fluorescent in situ hybridization (FISH) studie
Unmodified allogeneic peripheral blood stem cell transplantation (alloPBSCT) was performed in 20 consecutive acute non-lymphoblastic leukemia (ANLL) patients from their HLA-identical siblings. There were 11 males and 9 females. Median age was 34 years (range 17-43). Donors were primed with 2β’5-15 g/